丁伶伶，資格教授，碩士生導師，生理學教研室，郵箱：l.ding@ujs.edu.cn
【研究方向】
代謝性疾病如肥胖，糖尿病，非酒精性脂肪肝的早期診斷，發病機制及藥物靶點的研究
【學習工作經曆】
2021年12月-至今：江蘇大學醫學院 生理教研室
2017年9月-2021年5月：荷蘭馬斯特裡赫特大學醫學院獲得博士學位
2016年7月-2017年8月：北京凱因科技股份有限公司藥物研究院
2013年9月-2016年6月：天津中醫藥大學獲得藥劑學碩士學位
2009年9月-2013年7月：新鄉醫學院獲得醫學學士學位
【教改科研項目】
江蘇大學高層次人才科研啟動經費（5501280008），28萬，主持
【代表性論文】
1.Lingling Ding, Toon. J. I. De Munck, Yvonne Oligschlaeger, Jef Verbeek, Ger. H. Koek, Tom Houben, Ronit Shiri Sverdlov. Insulin resistance is positively associated with plasma cathepsin D activity in NAFLD patients. Biomolecular Concepts, August 2021; 12: 110–115.
2.Lingling Ding, Toon. J. I. De Munck, Yvonne Oligschlaeger, Inês Magro dos Reis, Jef Verbeek, Ger. H. Koek, Tom Houben, Ronit Shiri-Sverdlov. Myosteatosis in NAFLD patients correlates with plasma Cathepsin D. Biomolecular Concepts, 2021 May 15;12(1):27-35.
3.Lingling Ding, Tom Houben, Yvonne Oligschlaeger, Albert V. Bitorina, Bart Verwer, Maarten E. Tushuizen & Ronit Shiri-Sverdlov. Plasma Cathepsin D activity rather than levels correlates with metabolic parameters of type 2 diabetes in male individuals. (2020) Frontiers in Endocrinology. 11, 776.
4.Lingling Ding, Gijs H. Goossens，Yvonne Oligschlaeger, Tom Houben, Ellen E. Blaak & Ronit Shiri Sverdlov. Plasma cathepsin D activity is negatively associated with hepatic insulin sensitivity in overweight and obese humans. Diabetologia 63, 374–384 (2020)
5.Lingling Ding, Jiawei Li, Rui Huang, Zhidong Liu, Chunhua Li, Shaozi Yao, Jinyan Wang, Dongli Qi, Nan Li, Jiaxin Pi. Salvianolic acid B protects against myocardial damage caused by nanocarrier TiO2; and synergistic anti-breast carcinoma effect with curcumin via codelivery system of folic acid-targeted and polyethylene glycol-modified TiO2 nanoparticles, International Journal of Nanomedicine, 2016:11 5709–5727 (2019 impact factor: 5.115)
6.Lingling Ding, Zhidong Liu, Mike Okweesi Aggrey, Chunhua Li, Jing Chen and Ling Tong. Nanotoxicity: The Toxicity Research Progress of Metal and Metal-Containing Nanoparticles, Mini-Reviews in Medicinal Chemistry, 2015, 15, 529-542. (2019 Impact factor:2.733)
7.Albert V Bitorina, Yvonne Oligschlaeger, Lingling Ding, Tulasi Yadati, Annemary Westheim, Tom Houben, Rianne DW Vaes, Steven WM Olde Damink, Jan Theys, Ronit Shiri-Sverdlov. OxLDL as an Inducer of a Metabolic Shift in Cancer Cells. J Cancer. 2021 Aug 3;12(19):5817-5824.
8.Zhidong Liu#, Qian Zhang#, Lingling Ding, Chunhua Li, Zhongpeng Yin, Guoqiang Yan, Jiaxin Pi, Jiawei Li, Nan Li, Dongli Qi. Preparation procedure and pharmacokinetic study of water-in-oil nanoemulsion of Panax notoginseng saponins for improving the oral bioavailability, Current Drug Delivery, 2015, June 7.
9.Chunhua Li, Songlin Xu, Zhidong Liu, Lingling Ding, Xiaobin Zhao, Robert J Lee . (2016). Evaluation of a Non-aqueous Ibuprofen-Phospholipid Complex Formulation in Rats. In vivo (Athens, Greece), 30(4), 479–483.
10.Kati Mokkala, Johanna Gustafsson, Tero Vahlberg, Anita C E Vreugdenhil, Lingling Ding, Ronit Shiri-Sverdlov, Jogchum Plat, Kirsi Laitinen (2022). Serum CathepsinD in pregnancy: Relation with metabolic and inflammatory markers and effects of fish oils and probiotics. Nutrition, metabolism, and cardiovascular diseases : NMCD, 32(5), 1292–1300.
【教材與專著】
Lingling Ding, Yvonne Oligschlaeger, Ronit Shiri-Sverdlov, Tom Houben. Nonalcoholic Fatty Liver Disease. 2020 Mar 18. In: von Eckardstein A, Binder CJ, editors. Prevention and Treatment of Atherosclerosis: Improving State-of-the-Art Management and Search for Novel Targets [Internet]. Cham (CH): Springer; 2022;270:233-269.
【榮譽與兼職】
2022年度江蘇大學優秀學業導師
2022年江蘇省“雙創博士” （JSSCBS20221179）
